Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 772

1.

Quantum magnetisms in uniform triangular lattices Li2AMo3O8 (A = In, Sc).

Iida K, Yoshida H, Okabe H, Katayama N, Ishii Y, Koda A, Inamura Y, Murai N, Ishikado M, Kadono R, Kajimoto R.

Sci Rep. 2019 Feb 12;9(1):1826. doi: 10.1038/s41598-018-36123-7.

2.

The utility of transarterial embolization and computed tomography for life-threatening spontaneous retroperitoneal hemorrhage.

Tani R, Sofue K, Sugimoto K, Katayama N, Hamada MAS, Maruyama K, Horinouchi H, Gentsu T, Sasaki K, Ueshima E, Koide Y, Okada T, Yamaguchi M, Murakami T.

Jpn J Radiol. 2019 Jan 30. doi: 10.1007/s11604-019-00815-5. [Epub ahead of print]

PMID:
30701406
3.

Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab.

Suzuki K, Matsumoto T, Iwashita Y, Ishikura K, Fujioka M, Wada H, Katayama N, Imai H.

Int J Hematol. 2019 Jan 24. doi: 10.1007/s12185-019-02604-2. [Epub ahead of print]

PMID:
30680669
4.

Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies: comment.

Wada H, Matsumoto T, Yamashita Y, Ohishi K, Ikejiri M, Katayama N.

J Thromb Haemost. 2019 Jan 23. doi: 10.1111/jth.14395. [Epub ahead of print]

PMID:
30672649
5.

Giant isotropic negative thermal expansion in Y-doped samarium monosulfides by intra-atomic charge transfer.

Takenaka K, Asai D, Kaizu R, Mizuno Y, Yokoyama Y, Okamoto Y, Katayama N, Suzuki HS, Imanaka Y.

Sci Rep. 2019 Jan 15;9(1):122. doi: 10.1038/s41598-018-36568-w.

6.

The influence of horizontal cephalic rotation on the deviation of mandibular position.

Katayama N, Koide K, Koide K, Mizuhashi F.

J Adv Prosthodont. 2018 Dec;10(6):401-407. doi: 10.4047/jap.2018.10.6.401. Epub 2018 Dec 19.

7.

Expression of CD25 fluctuates in the leukemia-initiating cell population of CD25-positive AML.

Kageyama Y, Miwa H, Arakawa R, Tawara I, Ohishi K, Masuya M, Nakase K, Katayama N.

PLoS One. 2018 Dec 14;13(12):e0209295. doi: 10.1371/journal.pone.0209295. eCollection 2018.

8.

Type II Endoleak After Endovascular Aortic Aneurysm Repair Using the Endurant Stent Graft System for Abdominal Aortic Aneurysm with Occluded Inferior Mesenteric Artery.

Gentsu T, Okada T, Yamaguchi M, Horinouchi H, Katayama N, Ueshima E, Koide Y, Sofue K, Gotake Y, Nomura Y, Tanaka H, Okita Y, Sugimoto K, Murakami T.

Cardiovasc Intervent Radiol. 2018 Dec 4. doi: 10.1007/s00270-018-2140-8. [Epub ahead of print]

PMID:
30515534
9.

Tyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patients.

Sasaki T, Franco OE, Ohishi K, Filipovich Y, Ishii K, Crawford SE, Takahashi N, Katayama N, Sugimura Y, Hayward SW.

Prostate. 2019 Feb;79(3):259-264. doi: 10.1002/pros.23730. Epub 2018 Oct 28.

PMID:
30370673
10.

Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer.

Ogata T, Katsui K, Yoshio K, Ihara H, Katayama N, Soh J, Kuroda M, Kiura K, Maeda Y, Toyooka S, Kanazawa S.

Acta Med Okayama. 2018 Oct;72(5):507-513. doi: 10.18926/AMO/56249.

11.

Photo-induced semimetallic states realised in electron-hole coupled insulators.

Okazaki K, Ogawa Y, Suzuki T, Yamamoto T, Someya T, Michimae S, Watanabe M, Lu Y, Nohara M, Takagi H, Katayama N, Sawa H, Fujisawa M, Kanai T, Ishii N, Itatani J, Mizokawa T, Shin S.

Nat Commun. 2018 Oct 17;9(1):4322. doi: 10.1038/s41467-018-06801-1.

12.

Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.

Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, Plitman E, Sano Y, Tarumi R, ElSalhy M, Katayama N, Ogyu K, Miyazaki T, Kishimoto T, Graff-Guerrero A, Meyer JH, Blumberger DM, Daskalakis ZJ, Mimura M, Nakajima S.

Mol Psychiatry. 2018 Oct 12. doi: 10.1038/s41380-018-0252-9. [Epub ahead of print]

PMID:
30315224
13.

[Japanese Society of Hematology conflict of interest management in medical research].

Katayama N.

Rinsho Ketsueki. 2018;59(10):2390-2395. doi: 10.11406/rinketsu.59.2390. Japanese.

PMID:
30305550
14.

Evaluation of Setup Errors at the Skin Surface Position for Whole Breast Radiotherapy of Breast Cancer Patients.

Miyahara K, Kuroda M, Yoshimura Y, Aoyama H, Oita M, Sugianto I, Matsuzaki H, Ihara H, Katayama N, Katsui K, Kanazawa S, Asaumi J.

Acta Med Okayama. 2018 Aug;72(4):331-336. doi: 10.18926/AMO/56167.

15.

Production of Bioplastic Compounds by Genetically Manipulated and Metabolic Engineered Cyanobacteria.

Katayama N, Iijima H, Osanai T.

Adv Exp Med Biol. 2018;1080:155-169. doi: 10.1007/978-981-13-0854-3_7. Review.

PMID:
30091095
16.

Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy.

Wada H, Matsumoto T, Suzuki K, Imai H, Katayama N, Iba T, Matsumoto M.

Thromb J. 2018 Jul 11;16:14. doi: 10.1186/s12959-018-0168-2. eCollection 2018. Review.

17.

[A novel quantitative JAK2V617F detection kit: prospective clinical performance study comparing MPN patients and healthy subjects].

Kirito K, Koike M, Noguchi M, Kizaki M, Katayama N, Sugimoto Y, Dobashi N, Usui N, Komatsu N.

Rinsho Ketsueki. 2018;59(6):669-674. doi: 10.11406/rinketsu.59.669. Japanese.

PMID:
29973441
18.

Meta-analysis of the effects of rice-field abandonment on biodiversity in Japan.

Koshida C, Katayama N.

Conserv Biol. 2018 Dec;32(6):1392-1402. doi: 10.1111/cobi.13156. Epub 2018 Sep 6.

PMID:
29943862
19.

Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival.

Ito K, Saito S, Yorozu A, Kojima S, Kikuchi T, Higashide S, Aoki M, Koga H, Satoh T, Ohashi T, Nakamura K, Katayama N, Tanaka N, Nakano M, Shigematsu N, Dokiya T, Fukushima M; J-POPS Investigators.

Int J Clin Oncol. 2018 Jun 22. doi: 10.1007/s10147-018-1309-0. [Epub ahead of print]

PMID:
29934842
20.

Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab: comment.

Matsumoto T, Wada H, Toyoda H, Hirayama M, Yamashita Y, Katayama N.

J Thromb Haemost. 2018 Jun 7. doi: 10.1111/jth.14190. [Epub ahead of print] No abstract available.

PMID:
29877044
21.

Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature.

Nagaharu K, Masuya M, Kageyama Y, Yamaguchi T, Ito R, Kawakami K, Ito M, Katayama N.

J Med Case Rep. 2018 May 30;12(1):151. doi: 10.1186/s13256-018-1693-0. Review.

22.

Wide field-of-view crossed Dragone optical system using anamorphic aspherical surfaces.

Kashima S, Hazumi M, Imada H, Katayama N, Matsumura T, Sekimoto Y, Sugai H.

Appl Opt. 2018 May 20;57(15):4171-4179. doi: 10.1364/AO.57.004171.

PMID:
29791392
23.

Pressure-induced coherent sliding-layer transition in the excitonic insulator Ta2NiSe5.

Nakano A, Sugawara K, Tamura S, Katayama N, Matsubayashi K, Okada T, Uwatoko Y, Munakata K, Nakao A, Sagayama H, Kumai R, Sugimoto K, Maejima N, Machida A, Watanuki T, Sawa H.

IUCrJ. 2018 Jan 26;5(Pt 2):158-165. doi: 10.1107/S2052252517018334. eCollection 2018 Mar 1.

24.

Renal papillary tip extract stimulates BNP production and excretion from cardiomyocytes.

Goto I, Okamoto R, Hashizume R, Suzuki N, Ito R, Yamanaka K, Saito H, Kiyonari H, Tawara I, Kageyama Y, Ogihara Y, Ali Y, Yamada N, Katayama N, Ito M.

PLoS One. 2018 May 7;13(5):e0197078. doi: 10.1371/journal.pone.0197078. eCollection 2018.

25.

Resting-state functional connectivity analysis of the mouse brain using intrinsic optical signal imaging of cerebral blood volume dynamics.

Yoshida Y, Nakao M, Katayama N.

Physiol Meas. 2018 May 25;39(5):054003. doi: 10.1088/1361-6579/aac033.

PMID:
29697052
26.

Clinical Manifestation of Patients With Atypical Hemolytic Uremic Syndrome With the C3 p.I1157T Variation in the Kinki Region of Japan.

Matsumoto T, Toyoda H, Amano K, Hirayama M, Ishikawa E, Fujimoto M, Ito M, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Kawamura N, Ikejiri M, Kawakami K, Miyata T, Wada H.

Clin Appl Thromb Hemost. 2018 Nov;24(8):1301-1307. doi: 10.1177/1076029618771750. Epub 2018 Apr 25.

PMID:
29695177
27.

IL-2/IL-3 interplay mediates growth of CD25 positive acute myeloid leukemia cells.

Nakase K, Kita K, Katayama N.

Med Hypotheses. 2018 Jun;115:5-7. doi: 10.1016/j.mehy.2018.03.007. Epub 2018 Mar 20.

PMID:
29685196
28.

A Case of Psoriasis Complicated by Breast Cancer after Systemic Treatments Including Biologics.

Morizane S, Sugimoto S, Motoki T, Katayama N, Omori M, Iwatsuki K.

Acta Med Okayama. 2018 Apr;72(2):185-187. doi: 10.18926/AMO/55860.

29.

Oncological impact of neoadjuvant hormonal therapy on permanent iodine-125 seed brachytherapy in patients with low- and intermediate-risk prostate cancer.

Takamoto A, Tanimoto R, Bekku K, Araki M, Sadahira T, Wada K, Ebara S, Katayama N, Yanai H, Nasu Y.

Int J Urol. 2018 May;25(5):507-512. doi: 10.1111/iju.13555. Epub 2018 Apr 12.

PMID:
29651796
30.

[A Case of Poorly Differentiated Carcinoma of Unknown Primary Site with Risk of Choriocarcinoma Syndrome Effectively Treated with Reduced Bleomycin,Cisplatin ,Etoposide Combination Regimen(BEP Regimen)].

Okano M, Oda H, Ishihara M, Tamaru S, Saito K, Yamashita Y, Mizuno T, Katayama N.

Gan To Kagaku Ryoho. 2018 Apr;45(4):643-645. Japanese.

PMID:
29650822
31.

Classification of uterine artery angiographic images: a predictive factor of failure in uterine artery embolization for postpartum hemorrhage.

Ueshima E, Sugimoto K, Okada T, Katayama N, Koide Y, Sofue K, Morizane M, Tanimura K, Deguchi M, Yamaguchi M.

Jpn J Radiol. 2018 Jun;36(6):394-400. doi: 10.1007/s11604-018-0736-1. Epub 2018 Apr 5.

PMID:
29623551
32.

Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.

Yamaguchi M, Suzuki R, Kim SJ, Ko YH, Oguchi M, Asano N, Miyazaki K, Terui Y, Kubota N, Maeda T, Kobayashi Y, Amaki J, Soejima T, Saito B, Shimoda E, Fukuhara N, Tsukamoto N, Shimada K, Choi I, Utsumi T, Ejima Y, Kim WS, Katayama N.

Cancer Sci. 2018 Jun;109(6):2056-2062. doi: 10.1111/cas.13597. Epub 2018 Apr 28.

33.

Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers.

Tono Y, Ishihara M, Miyahara Y, Tamaru S, Oda H, Yamashita Y, Tawara I, Ikeda H, Shiku H, Mizuno T, Katayama N.

Oncotarget. 2018 Feb 16;9(19):14909-14921. doi: 10.18632/oncotarget.24504. eCollection 2018 Mar 13.

34.

Some adverse actions of chlorothalonil at sublethal levels in rat thymic lymphocytes: Its relation to Zn2.

Ikeda M, Deguchi J, Fukushima S, Qingyu A, Katayama N, Miura H, Oyama Y.

Environ Toxicol Pharmacol. 2018 Apr;59:61-65. doi: 10.1016/j.etap.2018.03.006. Epub 2018 Mar 8.

PMID:
29544185
35.

[Atypical hemolytic uremic syndrome with C3 p.I1157T missense mutation successfully treated with eculizumab].

Okano M, Matsumoto T, Nakamori Y, Ino K, Miyazaki K, Fujieda A, Sugimoto Y, Tawara I, Yamaguchi M, Ohishi K, Miwa H, Masuya M, Wada H, Katayama N.

Rinsho Ketsueki. 2018;59(2):178-181. doi: 10.11406/rinketsu.59.178. Japanese.

PMID:
29515070
36.

An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform.

Katayama H, Matsumoto T, Wada H, Fujimoto N, Toyoda J, Abe Y, Ohishi K, Yamashita Y, Ikejiri M, Habe K, Katayama N.

Clin Appl Thromb Hemost. 2018 Oct;24(7):1170-1176. doi: 10.1177/1076029618757344. Epub 2018 Feb 13.

PMID:
29439640
37.

Responses of macroinvertebrate communities to pesticide application in irrigated rice fields.

Stenert C, de Mello ÍCMF, Pires MM, Knauth DS, Katayama N, Maltchik L.

Environ Monit Assess. 2018 Jan 10;190(2):74. doi: 10.1007/s10661-017-6425-1.

PMID:
29322271
38.

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.

Wada H, Matsumoto T, Katayama N.

N Engl J Med. 2017 Nov 30;377(22):2193-4. doi: 10.1056/NEJMc1712683. No abstract available.

PMID:
29188947
39.

The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis.

Habe K, Wada H, Higashiyama A, Akeda T, Tsuda K, Mori R, Kakeda M, Matsumoto T, Ohishi K, Yamanaka K, Katayama N, Mizutani H.

Clin Appl Thromb Hemost. 2018 Sep;24(6):920-927. doi: 10.1177/1076029617736382. Epub 2017 Nov 12.

PMID:
29130325
40.

Superior mesenteric artery syndrome leading to reversible mucosal gangrene.

Uemura S, Suzuki K, Katayama N, Imai H.

Acute Med Surg. 2017 May 8;4(3):375-376. doi: 10.1002/ams2.283. eCollection 2017 Jul.

41.

Esophageal squamous cell neoplasia is an independent negative prognostic factor for head and neck cancer patients.

Hamada Y, Mizuno T, Tanaka K, Katsurahara M, Horiki N, Yamada R, Inoue H, Takei Y, Katayama N.

Int J Clin Oncol. 2018 Apr;23(2):243-248. doi: 10.1007/s10147-017-1201-3. Epub 2017 Oct 24.

PMID:
29063984
42.

Successful Pulmonary Artery Embolization for the Management of Hemoptysis in a Patient with Eisenmenger Syndrome Caused by Patent Ductus Arteriosus.

Tamada N, Nakayama K, Shinkura Y, Yanaka K, Katayama N, Okada T, Yamaguchi M, Matsumoto K, Tanaka H, Shinke T, Emoto N, Hirata KI.

Intern Med. 2017 Dec 15;56(24):3299-3304. doi: 10.2169/internalmedicine.9071-17. Epub 2017 Oct 11.

43.

Ultrafast Electronic Band Gap Control in an Excitonic Insulator.

Mor S, Herzog M, Golež D, Werner P, Eckstein M, Katayama N, Nohara M, Takagi H, Mizokawa T, Monney C, Stähler J.

Phys Rev Lett. 2017 Aug 25;119(8):086401. doi: 10.1103/PhysRevLett.119.086401. Epub 2017 Aug 23.

PMID:
28952776
44.

Role of prostaglandin E2 in bronchoconstriction-triggered cough response in guinea pigs.

Okazaki A, Hara J, Ohkura N, Fujimura M, Sakai T, Abo M, Katayama N, Kasahara K, Nakao S.

Pulm Pharmacol Ther. 2018 Feb;48:62-70. doi: 10.1016/j.pupt.2017.09.003. Epub 2017 Sep 22.

PMID:
28951192
45.

Successive Dimensional Transition in (TMTTF)_{2}PF_{6} Revealed by Synchrotron X-ray Diffraction.

Kitou S, Fujii T, Kawamoto T, Katayama N, Maki S, Nishibori E, Sugimoto K, Takata M, Nakamura T, Sawa H.

Phys Rev Lett. 2017 Aug 11;119(6):065701. doi: 10.1103/PhysRevLett.119.065701. Epub 2017 Aug 7.

PMID:
28949642
46.

Scaling of Memories and Crossover in Glassy Magnets.

Samarakoon AM, Takahashi M, Zhang D, Yang J, Katayama N, Sinclair R, Zhou HD, Diallo SO, Ehlers G, Tennant DA, Wakimoto S, Yamada K, Chern GW, Sato TJ, Lee SH.

Sci Rep. 2017 Sep 21;7(1):12053. doi: 10.1038/s41598-017-12187-9.

47.

A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study).

Kobayashi T, Nannya Y, Ichikawa M, Oritani K, Kanakura Y, Tomita A, Kiyoi H, Kobune M, Kato J, Kawabata H, Shindo M, Torimoto Y, Yonemura Y, Hanaoka N, Nakakuma H, Hasegawa D, Manabe A, Fujishima N, Fujii N, Tanimoto M, Morita Y, Matsuda A, Fujieda A, Katayama N, Ohashi H, Nagai H, Terada Y, Hino M, Sato K, Obara N, Chiba S, Usuki K, Ohta M, Imataki O, Uemura M, Takaku T, Komatsu N, Kitanaka A, Shimoda K, Watanabe K, Tohyama K, Takaori-Kondo A, Harigae H, Arai S, Miyazaki Y, Ozawa K, Kurokawa M; for National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Am J Hematol. 2017 Dec;92(12):1324-1332. doi: 10.1002/ajh.24905. Epub 2017 Sep 28.

48.

An Evaluation of the Activated Partial Thromboplastin Time Waveform.

Matsumoto T, Wada H, Fujimoto N, Toyoda J, Abe Y MR, Ohishi K, Yamashita Y, Ikejiri M, Hasegawa K, Suzuki K, Imai H, Nakatani K, Katayama N.

Clin Appl Thromb Hemost. 2018 Jul;24(5):764-770. doi: 10.1177/1076029617724230. Epub 2017 Sep 8.

PMID:
28884611
49.

Monitoring of hemostatic abnormalities in major orthopedic surgery patients treated with edoxaban by APTT waveform.

Hasegawa M, Wada H, Tone S, Yamaguchi T, Wakabayashi H, Ikejiri M, Watanabe M, Fujimoto N, Matsumoto T, Ohishi K, Yamashita Y, Katayama N, Sudo A.

Int J Lab Hematol. 2018 Feb;40(1):49-55. doi: 10.1111/ijlh.12727. Epub 2017 Sep 4.

PMID:
28869359
50.

Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.

Tawara I, Kageyama S, Miyahara Y, Fujiwara H, Nishida T, Akatsuka Y, Ikeda H, Tanimoto K, Terakura S, Murata M, Inaguma Y, Masuya M, Inoue N, Kidokoro T, Okamoto S, Tomura D, Chono H, Nukaya I, Mineno J, Naoe T, Emi N, Yasukawa M, Katayama N, Shiku H.

Blood. 2017 Nov 2;130(18):1985-1994. doi: 10.1182/blood-2017-06-791202. Epub 2017 Aug 31.

Supplemental Content

Loading ...
Support Center